π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This study proposes a double blind randomized clinical trial to include nor...
Status
Completed
Location
Columbia University Medical Center
Start Date
2006-07
Trial ID
NCT00827632
Treatments Being Tested
This is a Phase 1, randomized, 2 way crossover, open-label study of the eff...
Status
Completed
Location
Quotient Sciences Screening Office
Start Date
2019-08-09
Trial ID
NCT04018274
Treatments Being Tested
The purpose of this clinical study is to find out if NNC0662-0419 is safe a...
Status
Recruiting
Location
Altasciences Clinical Kansas, Inc.
Start Date
2026-04-07
Trial ID
NCT07525791
Treatments Being Tested
The purpose of this study is to evaluate the effect of multiple 40 milligra...
Status
Completed
Location
SGS Life Science Services
Start Date
2017-08-14
Trial ID
NCT03249402
Treatments Being Tested
This Phase 1 study will assess the pharmacokinetic effect of multiple doses...
Status
Completed
Location
Quotient Sciences Screening Office
Start Date
2020-08-24
Trial ID
NCT04267250
Treatments Being Tested
This is a Phase 1, randomized, 2 way crossover, open-label study of the eff...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2018-09-26
Trial ID
NCT03662516
Treatments Being Tested
The purpose of this study is to see how a medicine called PF-08049820 affec...
Status
Active Not Recruiting
Location
Pfizer Clinical Research Unit - New Haven
Start Date
2025-10-03
Trial ID
NCT07190430
Treatments Being Tested
The purpose of this clinical study is to find out if UBT251 is safe and eff...
Status
Recruiting
Location
Altasciences Clinical Company, Inc
Start Date
2026-07-17
Trial ID
NCT07710729
Treatments Being Tested
This study is designed to assess whether co-administration of CP-690,550 an...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-06
Trial ID
NCT01137708
The main purpose of this study is to evaluate the effects of repeat dosing ...
Status
Completed
Location
Pratia MCM Krakow
Start Date
2017-10-20
Trial ID
NCT03301207
Treatments Being Tested